Morgan Stanley’s ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share ATIP.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding ATIP.WS
FIG
ICM
PFM
LP
SCC
TCM
Morgan Stanley's ATIP.WS Position: Q1 2022 in Review
Morgan Stanley sold out of ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share (ATIP.WS) in Q1 2022, closing a stake of 24 shares.
Morgan Stanley first reported a position in ATIP.WS in Q2 2021 and held it in 3 quarters. The position peaked at $0 in Q4 2021. 18 funds tracked by Wall St. Rank hold ATIP.WS as of Q1 2022.
- Morgan Stanley reported no remaining ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position as of Q1 2022 after selling out during the quarter.
- Morgan Stanley sold 24 ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share shares in Q1 2022.
- Morgan Stanley first reported a position in ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share in Q2 2021 and held it in 3 quarters.
- Morgan Stanley's ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position peaked at $0 in Q4 2021.
- 18 funds tracked by Wall St. Rank held ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share as of Q1 2022.
Based on Morgan Stanley's 13F filing for Q1 2022, filed 13 May 2022.